Literature DB >> 7581385

Linkage of autosomal dominant iris hypoplasia to the region of the Rieger syndrome locus (4q25).

E Héon1, B P Sheth, J W Kalenak, S L Sunden, L M Streb, C M Taylor, W L Alward, V C Sheffield, E M Stone.   

Abstract

Iris hypoplasia is an autosomal dominant disorder which is frequently associated with glaucoma. This glaucoma is usually resistant to medical therapy and can lead to blindness. A large family of Scandinavian descent with a five generation history of iris hypoplasia was studied. Fifteen individuals were found to have iris hypoplasia, nine of whom had associated glaucoma. In an attempt to identify the chromosomal location of the disease-causing gene, this family was genotyped with short tandem repeat polymorphisms (STRPs) known to map to loci previously associated with glaucoma. The juvenile glaucoma locus at 1q25 and a congenital glaucoma locus on 6p were both statistically excluded. However, significant linkage was demonstrated at the Rieger syndrome locus at 4q25. The highest observed LOD score was 3.70 (theta = 0) and was obtained with marker D4S1616. Three recombination events were observed in affected individuals that together demonstrate that the disease-causing gene lies between markers ACT3E03 and D4S1611, an interval of approximately 7 cM. These results suggest that autosomal dominant iris hypoplasia and Rieger syndrome are allelic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581385     DOI: 10.1093/hmg/4.8.1435

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Autosomal dominant Axenfeld-Rieger anomaly maps to 6p25.

Authors:  D B Gould; A J Mears; W G Pearce; M A Walter
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  A second locus for Rieger syndrome maps to chromosome 13q14.

Authors:  J C Phillips; E A del Bono; J L Haines; A M Pralea; J S Cohen; L J Greff; J L Wiggs
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

3.  Familial glaucoma iridogoniodysplasia maps to a 6p25 region implicated in primary congenital glaucoma and iridogoniodysgenesis anomaly.

Authors:  T Jordan; N Ebenezer; R Manners; J McGill; S Bhattacharya
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

4.  Mapping of a congenital microcoria locus to 13q31-q32.

Authors:  C Rouillac; O Roche; D Marchant; L Bachner; A Kobetz; P J Toulemont; C Orssaud; M Urvoy; S Odent; B Le Marec; M Abitbol; J L Dufier
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

5.  Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy.

Authors:  A P Brézin; A Béchetoille; P Hamard; F Valtot; M Berkani; A Belmouden; M F Adam; S Dupont de Dinechin; J F Bach; H J Garchon
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

6.  Autosomal dominant iridogoniodysgenesis anomaly maps to 6p25.

Authors:  A J Mears; F Mirzayans; D B Gould; W G Pearce; M A Walter
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

Review 7.  Molecular genetics of the glaucomas: mapping of the first five "GLC" loci.

Authors:  V Raymond
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

8.  Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene.

Authors:  Andrea L Vincent; Gail Billingsley; Yvonne Buys; Alex V Levin; Megan Priston; Graham Trope; Donna Williams-Lyn; Elise Héon
Journal:  Am J Hum Genet       Date:  2002-01-03       Impact factor: 11.025

9.  A novel Asp380Ala mutation in the GLC1A/myocilin gene in a family with juvenile onset primary open angle glaucoma.

Authors:  A M Kennan; F C Mansergh; J H Fingert; T Clark; C Ayuso; P F Kenna; P Humphries; G J Farrar
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

Review 10.  Recent advances in molecular genetics of glaucoma.

Authors:  Kunal Ray; Arijit Mukhopadhyay; Moulinath Acharya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.